[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)] [Notices] [Pages 57089-57090] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2012-22874] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Chronic Fatigue Syndrome Advisory Committee AGENCY: Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a meeting. The meeting will be open to the public. DATES: The meeting will be held on Wednesday, October 3, 2012 and Thursday, October 4, 2012 from 9 a.m. until 5 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building; 200 Independence Avenue SW., Room 800, Washington, DC 20201. For a map and directions to the Hubert H. Humphrey building, please visit http://www.hhs.gov/about/hhhmap.html. FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, M.D., Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee, Department of Health and Human Services, 200 Independence Avenue SW., Room 712E, Washington, DC 20201. Any questions about meeting registration or public comment sign-up should be directed to [email protected]. Please direct other inquiries to [email protected]. SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002 to advise, consult with, and make recommendations to the Secretary through the Assistant Secretary for Health, on a broad range of topics including: (1) The current state of knowledge and research on the epidemiology, etiologies, biomarkers, treatment, and risk factors relating to chronic fatigue syndrome (CFS), to identify potential opportunities in these areas; (2) the impact and implications of current and proposed diagnosis and treatment methods for CFS; (3) development and implementation of programs to inform the public, health care professionals, and the biomedical research communities about CFS; and (4) strategies to improve the quality of life for CFS patients. The agenda for this meeting is being developed and will be posted on the CFSAC Web site, http://www.hhs.gov/advcomcfs when finalized. The meeting will be live-video streamed at www.HHS.gov/Live and archived through the CFSAC Web site: www.hhs.gov/advocomcfs. Listening-only audio via telephone will be available on both days. Call-in information will be posted on the CFSAC Web site. Individuals who plan to attend should register at the following link by September 28, 2012: http://www.blsmeetings.net/CFSACOctober2012. Attendance by visitors who are not U.S. citizens is welcome, but prior approval is required by sending a request to [email protected]. Members of the media will also need to register. All attendees will be required to show government- issued picture identification (state or federal) for entry into the federal building. Attendees will receive a wrist band that must be worn the entire time. Security requires all non-federal employees to be escorted the entire time they are in the building. Upon leaving the building for any reason individuals will be required to follow the security steps mentioned above and receive a new wrist band. Members of the public will have the opportunity to provide public comments at the meeting or via telephone. International calls cannot be accommodated. A separate sign-up process for requesting time for public comment must be completed by September 24, 2012 at the following link: http://www.blsmeetings.net/CFSACPublicCommentOctober2012. It is requested that individuals wishing to provide public comment submit a copy of their testimony (5 pages or less) in advance. It is preferred that individuals email their testimony (in MS WORD format, single spaced, using a 12 point font) to [email protected] by Monday, September 24, 2012. Testimony may also be mailed to the following address: Chronic Fatigue Syndrome Advisory Committee, Department of Health and Human Services, 200 Independence Avenue SW. Room 712E, Washington, DC, 20201. Mailed testimony must be received no later than Monday, September 24, 2012. Note: PDF files, hand-written notes and photographs will not be accepted. Requests for public comment and written testimony will not be accepted through the CFSAC mailbox. Also, the CFSAC mailbox will not respond to questions about specific public comment requests. All public comment becomes part of the public record, available for viewing and posted on the CFSAC Web site. All testimony and printed material submitted for the meeting are part of the official meeting record and will be uploaded to the CFSAC Web site and made available for public inspection. Testimony and materials submitted should not include sensitive personal information, such as social security number, birthdates, driver's license number, state identification or foreign country equivalent, passport number, financial account number, or credit or debit card number. Sensitive health information, or non- public corporate or [[Page 57090]] trade association information, such as trade secrets or other proprietary information should be excluded from any materials submitted. If you wish to remain anonymous the document must specify this. We will confirm your time for public comment via email by September 28, 2012. Each speaker will be limited to five minutes per speaker; no exceptions will be made. We will give priority to individuals who have not provided public comment within the previous year. Persons who wish to distribute printed materials to CFSAC members should submit one copy to Designated Federal Officer at [email protected], prior to Friday, September 28, 2012. Submissions are limited to five typewritten pages. Dated: September 4, 2012 Nancy C. Lee, Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee. [FR Doc. 2012-22874 Filed 9-14-12; 8:45 am] BILLING CODE 4150-42-P